Recently Released Market Study: Calming and Sleeping in Japan
Value sales of calming and sleeping declined by 4% in 2011, because the market has reached saturation. Sales grew quickly by a CAGR of 31% between 2003 and 2009, with SSP Co Ltd's launch of Drewell, which was the first OTC medicine to include the active ingredient diphenhydramine hydrochloride. In 2007, other manufacturers entered the market to take advantage of its rapid growth. Taisho Pharmaceutical Co Ltd launched Neody and Resty, while GlaxoSmithKline KK introduced Nytol.
View full press release